Chiral Oligonucleotide Preparation With Selective Post-Modification Capping
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Existing oligonucleotide synthesis methods, particularly those involving chiral auxiliaries, suffer from the generation of impurities and inefficiencies due to uncapped reactive functional groups, leading to reduced crude product purity and yield, especially in stereoselective oligonucleotide synthesis.
Innovation Solution
Implementing a post-modification capping step and strategically positioning capping steps using amidation conditions instead of esterification, with reduced levels of strong nucleophiles, to selectively cap amino and hydroxyl groups, thereby improving crude purity and yield.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Manufacturing precision
If traditional oligonucleotide synthesis methods are used, then oligonucleotides can be produced, but impurities are generated due to uncapped reactive functional groups, reducing crude product purity
Solution Approach 1:
The patent introduces a capping step performed immediately after the modification step, before the next coupling step begins. This preliminary capping action prevents reactive functional groups from generating impurities during subsequent synthesis steps, thereby improving crude product purity without affecting synthesis throughput
Solution Approach 2:
The patent converts the potentially harmful uncapped reactive functional groups into beneficial capped groups by performing capping reactions. This transforms what would be sources of impurity generation into controlled modifications that actually improve product purity while maintaining synthesis efficiency
2Manufacturing precision
If traditional synthesis methods with full capping are used, then impurity formation is reduced, but synthesis time increases due to additional capping steps
Solution Approach 1:
The patent applies capping selectively only at critical points in the synthesis cycle - specifically immediately after modification steps where reactive functional groups are generated. This partial capping approach provides sufficient purity improvement without requiring comprehensive capping at every step, thereby minimizing time loss
Solution Approach 2:
The patent optimizes capping reaction parameters including reagent selection, concentration, and reaction time to achieve effective capping in minimal time. By adjusting these parameters, the synthesis cycle time is reduced while maintaining high crude product purity
3Manufacturing precision
If chiral auxiliaries are used for stereoselective synthesis, then stereochemistry control is improved, but operational complexity increases due to additional steps and conditions
Solution Approach 1:
The patent combines the capping step with the modification step by performing capping immediately after modification within the same operational sequence. This merging eliminates the need for separate, complex capping procedures and simplifies the overall stereoselective synthesis operation while maintaining high stereochemistry control
Solution Approach 2:
The patent develops capping reagents and conditions that serve multiple functions - they cap reactive functional groups, maintain chiral integrity, and prepare the oligonucleotide for the next coupling step. This multi-functionality reduces operational complexity by eliminating the need for separate specialized steps
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The proposed methods significantly enhance crude product purity and yield by minimizing byproduct formation and improving operational efficiency in oligonucleotide synthesis, particularly for chirally controlled compositions.
Implementation Method 1
strategically positioning capping steps using amidation conditions instead of esterification, with reduced levels of strong nucleophiles, to selectively cap amino and hydroxyl groups
Data Source
AI summary
Among other things, the present disclosure provides technologies for oligonucleotide preparation, particularly chirally controlled oligonucleotide preparation, which technologies provide greatly improved crude purity and yield, and significantly reduce manufacturing costs.